Rheonix Inc, a molecular diagnostics device manufacturer based in Ithaca, New York, has integrated Tecan's Cavro® Air Displacement Pipettor (ADP) into its EncompassMDx™ molecular platform, providing complete automation of sample processing and analysis using Rheonix CARD® technology.
AdvantaPure's molded silicone manifold connections, available in tee, wye, cross and reducer styles, are now guaranteed leak-proof. The company uses only high quality materials, precise manufacturing, and extensive quality controls, resulting in connections that prevent leaks of valuable pharmaceutical and biopharmaceutical fluids.
Malcolm Moos, Medical Officer of Cellular,Tissue and Gene Therapies at the Center for Biologics Evaluation and Research of FDA will present on "Characterization of cell-based regenerative medicine products-current challenges and possible solutions" at the Stem Cell Summit 2013 on April 29-30, 2013 in Boston, MA.
David Lewis, Vice President of Biology at Arrowhead Research, will present on "DPC Technology for siRNA Delivery: Moving from Platform to Pipeline" at GTC's 4th RNAi Research & Therapeutics Conference on June 20-21, 2013 in San Francisco, CA.
Gregory Bonfiglio from Proteus Venture Partners, will give a presentation on "Funding for Regenerative Medicine Technologies: Opportunities And Challenges" at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA).
Kathrin Jansen, Senior Vice President at Pfizer, Will Give a Keynote Presentation titled "A Novel Multi-antigen Vaccine to Prevent Staphylococcus Aureus Infection and Disease. Can We Beat the Bug at Its Own Game?" at GTC's 11th Vaccines Research & Development: All Things Considered Conference on July 8-10, 2013 in Boston, MA.
Klaus Stohr, Vice President and Global Head of Influenza Franchises at Novartis, Will Give a Keynote Presentation titled "Global Trends in Pandemic Preparedness: Changes After the Last Pandemic?" at GTC's 2nd Influenza Research & Development Conference on July 8-10, 2013 in Boston, MA.
Mark Kay, Professor of Pediatrics and Genetics at Stanford University, will give a keynote presentation on microRNAs at the 4th RNAi Research & Therapeutics Conference on June 20-21, 2013 in San Francisco, CA.
Dr. Istvan Enyedy, Senior Scientist of Chemistry at Biogen-Idec, will speak on "New In Silico Strategies for Hit-Identification and Optimization" at GTC's 7th Drug Design & Medicinal Chemistry Conference, May 8-10, 2013 in Boston, MA.
Sridaran Natesan, Vice President of External Innovation at Sanofi will give a keynote presentation on "How To Make Pancreatic Beta Cells" at the Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA).
Tiina Palomaki, Senior Researcher at The European Medicines Agency will present on "Regulatory Requirements for Stem Cell-based Medicinal Products in the EU" at GTC's Stem Cell Summit 2013 (Apr 29-30, 2013 in Boston, MA).
David Swinney, CEO and Co-Founder of the Institute for Rare & Neglected Diseases Drug Discovery to Present at the 7th Drug Design & Medicinal Chemistry conference (May 8-10, 2013 in Boston, MA).
Mostafa Ronaghi, Senior Vice President and Chief Technology Officer of Illumina Will Give a Keynote Presentation on "The New Era of Medicine Enabled by Advancing NextGen Sequencing" at GTC's 3rd Next Generation Sequencing Conference on June 20-21, 2013 in San Francisco, CA.
Paula Jacobs, Associate Director of Division of Cancer Treatment and Diagnosis at the National Cancer Institute's Cancer Imaging Program, to speak on "Translational Molecular Imaging: Promises and Pitfalls" at GTC's 6th Imaging in Drug Discovery and Development Conference (May 8-10, 2013 in Boston, MA).
Peter Lee, Professor and Associate Chair of Cancer Immunotherapeutics and Tumor Immunology (CITI) at City of Hope and Beckman Research Institute Beckman Center, will speak on "Immune Cells in Tumor-Draining Lymph Nodes: Novel Prognostic Indicators for Breast Cancer" at the 6th Imaging in Drug Discovery and Development Conference (May 8-10, 2013 in Boston, MA).
The conference will have talks by leading scientists and doctors from around the world and feature new research papers on the uses of GcMAF to restore the body's immune system to full strength to fight diseases, autism and cancer.
AdvantaPure will exhibit at several key trade shows this spring. Events include BioPharma Asia, the PDA Annual Meeting, BioProcess International Europe, Interphex, TechnoPharm, and Single Use Applications for Biopharm Manufacturing. AdvantaPure staff members will meet with customers, prospects, and potential distributors to discuss single use process systems and fluid transfer hose.
George Weinstock, Leader of the Human Microbiome Project and Professor of Genetics and Molecular Microbiology at Washington University at St. Louis, Will Give a Keynote Presentation on "The Microbiome, Infectious Diseases, and NGS" at GTC's 3rd Next Generation Sequencing Conference on June 19-21, 2013 in San Francisco, CA.
Researchers at The Virginia G. Piper Center for Personalized Diagnostics at the Biodesign Institute, Arizona State University, have invested in an HS 4800™ Pro automated hybridization station and two PowerScanner™ units from Tecan for processing protein microarrays.
Protein Signal now offers a Mouse Anti-PEG Monoclonal Antibody , a new member of THETM Elite series, which represents THE best quality antibody in the industry.
Scientists at the University of Toronto, Canada, have chosen generations of Tecan microplate readers to monitor the effects of environmental or drug perturbation on molecularly barcoded yeasts.
GenScript USA Incorporation has launched the eBlot® Protein Transfer System, a semi-dry electric blotter for transferring proteins from mini polyacrylamide gels onto membranes in 7 to 10 minutes, expanding its bench-top tool offerings for protein analysis. This system simplifies the process further by including a complete line of accessories, eliminating the need for additional buffers.
With the completion of an extensive new animal facility and validation of ground-breaking new immunization protocols, GenScript is able to offer this new antibody package at a staggeringly fast delivery time of just 45 days, 2 months faster than traditional immunization methods.
M. Ian Phillips, Norris Life Professor and Director of the Center for Rare Disease Therapies at the Keck Graduate Institute to Present on "Gene and Stem Cell Therapies" at the Inaugural Orphan Drugs Research and Commercialization Conference (May 8-10, 2013 in Boston, MA).
Satisfied Users & 
Approved Press Releases
